Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify">CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- <strong>Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) ("Adial" or the "Company"),</strong> a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that Cary Claiborne, CEO of Adial...